A Case with Lethal Endobronchial Lymphoma Presenting with Respiratory Failure Requiring Intubation and Mechanical Ventilation
Zhang Gen-Sheng,Xu Zhi-Hao,Cui Wei,Zhou Fang,Xia Yi,Wen Li,Li,Shen Hua-Hao
DOI: https://doi.org/10.1097/00029330-200802010-00021
2008-01-01
Abstract:Non-Hodgkin’s lymphoma (NHL) affects thoracic structures, particularly mediastinum and lung parenchyma, in up to 43% of patients at some stage in the course of the disease.1 Endobronchial involvement, however, is extremely rare, even in the presence of advanced disease. Since the first report of endobronchial NHL in 1955,2 there were few reports on the cases with this disease identified by bronchoscopic examination in the English literature.3-14 To our knowledge, the patient described in this report is an extremely rare case presenting with respiratory failure as the initial manifestation requiring intubation and mechanical ventilation soon after admission. CASE REPORT An 18-year-old girl was admitted to our hospital on March 18, 2006 with a history of nonproductive cough and progressive dyspnea for a week. She had no history of night sweat, fever, or chest pain. On admission, the patient was conscious. Stridor was heard over the neck. Auscultation revealed prolonged expiration, wheezes and crackles in both lungs. There was no peripheral lymphadenopathy. The results of arterial blood gas in room air on admission were as follows: pH 7.423, PCO2 23.9 mmHg, PO2 56.8 mmHg, SaO2 90.2%. Chest X-ray was unremarkable (Figure 1A). Severe asthma was suspected initially based on the above mentioned findings. Then, anti-asthmatic drugs were given, but no improvement was observed. Because of persistent dyspnea and respiratory failure, the patient was intubated and transferred to intensive care unit (ICU) 24 hours after admission. Because of high fever (up to 39.8°C) and positive sputum cultures, broad-spectrum antibiotics and supporting treatments were prescribed. Although the patient was treated with mechanical ventilation, hypercapnic acidosis and high airway pressure were persistent, atelectasis of the right upper lobe on chest X-ray (Figure 1B) was noted on the second day after being transferred to ICU. In view of the possibility of massive mucus embolus, we enhanced the parameters of mechanical ventilation, and mild improvement for 3 days was paralleled with the improved aeration of the right upper lobe on chest X-ray (Figure 1C). However, the patient’s condition was deteriorated, and the bedside X-ray (Figure 1D) showed the transposition of mediastinum and heart to the left side, and the complete left lung consolidation and atelectasis on the fifth day after transferred to ICU. Bronchoscopy was performed for biopsy and pathological examination on March 26, 2006, which disclosed a polypoid mass, located 1.5 cm below the carina, causing total occlusion of the left main bronchus. Histology of the biopsy showed chronic inflammation. Three days later, the second bronchoscopy showed strangely a new polypoid mass causing nearly total occlusion of the right intermediate bronchus besides the above findings of the first bronchoscopy. Histopathological analysis of the repeated biopsy revealed infiltration of medium-sized lymphoma cells with abundant cytoplasm (Figure 2). Immunohistochemical staining showed that the patient’s biopsy specimen was strongly positive for leukocyte common antigen (LCA), CD3, CD45RO and Ki-67, while was negative for CD20, CD30, CD56, CD5 and Epstein-Barr virus (Figure 3). A monoclonal band in polymerase chain reaction (PCR) analysis indicated T cell receptor (TCRβ) gene rearrange ment (Figure 4).These findings confirmed the diagnosis of endotracheal NHL (peripheral T-cell lymphoma, unspecified). Staging investigations were performed, bed-side abdominal ultrasound showed no hepatospleno- megaly and no retroperitoneal lymphadenopathy, but the patient’s situation did not allow us to perform CT of the chest, abdomen or pelvis. Unfortunately the patient died of respiratory failure on March 30, 2006 with no opportunity for stenting and/or laser therapy.Figure 1.: Posteroanterior chest X-ray film of the patient. Unremarkable (A), atelectasis of the right upper lobe (B), improved aeration of the right upper lobe (C), the transposition of mediastinum and heart to the left side, and the complete left lung consolidation and atelectasis (D).Figure 2.: The photomicrographs of the endobronchial biopsy specimen showing an infiltrate of medium-sized lymphoma cells with abundant cytoplasm (HE, A: original magnification ×100; and B: original magnification ×400).Figure 3.: Immunohistochemical staining for the pathological sections (original magnification × 400). LCA, CD3 and CD45RO were positive (A-C, respectively); CD20 was negative on the cell membrane of the lymphoma cells (D).Figure 4.: Polymerase chain reaction (PCR) analysis of the endobronchial specimen showing a band due to T cell receptor (TCRβ) gene rearrangement (arrow).DISCUSSION The current case survived only for 13 days after admission. The direct reason for the patient’s death was the delay in achieving correct diagnosis. The reasons for the delay were as follows: since endobronchial NHL is extremely rare and no case was reported in China, we knew little about it; because of the symptoms similar to those of asthma and normal chest X-ray on admission, the patient was misdiagnosed as severe asthma; though there was no improvement after anti-asthmatic medication, temporary alleviation of respiratory failure after mechanical ventilation in ICU was observed, so we considered simply massive mucus embolus might explain the progressive dyspnea and ignored the urgency for bronchoscopy. Two biopsies were performed for the diagnosis, which delayed three days for the correct diagnosis. The progressive exacerbation of the endobronchial NHL itself, was confirmed by the two different findings of bronchoscopy. When we obtained the correct diagnosis, the patient died of severe respiratory failure and lost the chance for stent planting/laser therapy. Immediate relief of obstruction can be accomplished by bronchoscopy with laser or stenting in most patients,6,9,12 thus some authors suggested that the use of stent for palliative treatment of life-threatening airway obstruction might be required prior to or as an initial adjunct to tumor-specific therapy.6 The several possible mechanisms of endobronchial NHL11,13 include: direct bronchial invasion from a parenchymal mass; direct bronchial invasion from a mediastinal mass; lymphatic spread to peribronchial connective tissues; transbronchial aspiration of tumor emboli; and direct hematogenous metastasis. The most common mechanisms for the endobronchial metastasis of NHL probably involve direct bronchial invasion and lymphatic spread. With bulky hilar or mediastinal adenopathy, direct extension to adjacent bronchi is possible. Rose et al13 classified endobronchial NHL into two types on the basis of the clinical and radiological appearances. The more common form, type 1, occurs in the presence of systemic lymphoma and shows diffuse submucosal infiltrates. The rare form, type 2, occurs in the absence of clinically apparent systemic lymphoma and shows central airway involvement by a solitary mass. Although the current case had no work-up by CT of the chest, abdomen or pelvis and no medical history of systemic lymphoma, these characters of multiple endobronchial lesions and relatively poor prognosis suggested that the current case would be categorized as type 1.12 The diagnosis of endobronchial NHL is relatively difficult because symptoms and chest X-ray are usually nonspecific. Some cases with endobronchial NHL had no symptoms although there was abnormal chest X-ray finding.3 Though CT of chest may be useful for affording much detailed signs (such as features of lesions and lymph nodes of mediastinum or bronchi), we often can not make a definitive diagnosis of endobronchial NHL and differentiate it from other diseases including carcinoid tumour, mucoepidermoid tumour, endobronchial metastasis, inflammatory pseudotumour, Hodgkin’s disease, and fungal infection. Bronchoscopic examination with biopsy is mandatory and constructive because it allows tissue specimens to be obtained from the tumour both proximally and distally, and most of the final diagnoses are confirmed thereby. To classify the types of endobronchial NHL, immunohistochemistry is necessary, and gene rearrangement and cytogenetic examination are alternative. As for the current case, the lessons we could learn from it are as follows: (1) The current case was initially diagnosed as asthma while the definitive diagnosis was endobronchial NHL, which showed the fact that not all wheezes are attributable to asthma. It is critical to bear in mind that if a patient does not respond to appropriate anti-asthma therapy, localized obstructions should be ruled out before establishing the diagnosis of asthma. (2) Bronchoscopic examination with biopsy is mandatory and constructive for the definitive diagnosis of endobronchial and endotracheal diseases. Therefore, it should be performed as early as possible. (3) Two biopsies were performed in many other cases9,14,15 as well as in the current case before correct diagnosis because histology of the biopsy specimen often shows chronic inflammation. This suggests that we need to be more careful with biopsy. Multi-locus biopsy and adequate amount of samples are essential for the successful and timely diagnosis. In summary, although endobronchial non-Hodgkin’s lymphoma is very rare, physicians should recognize the disease when patients present with unexplained airway obstruction as what was seen in this case, and bronchoscopic examination with biopsy should be performed immediately to make definitive diagnosis.